nach oben

Reactions Weekly

Erschienen in:

01.10.2018 | Case report

Antineoplastics

Transformation of diffuse large B cell lymphoma, acute myeloid leukaemia and myelodysplastic syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Hiraga J, et al. Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab. Annals of Hematology 97: 2253-2255, No. 11, Nov 2018. Available from: URL: http://doi.org/10.1007/s00277-018-3354-1 - JapanCrossRef

Titel: Antineoplastics
Transformation of diffuse large B cell lymphoma, acute myeloid leukaemia and myelodysplastic syndrome: case report
Publikationsdatum: 01.10.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-53379-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Antineoplastics

Transformation of diffuse large B cell lymphoma, acute myeloid leukaemia and myelodysplastic syndrome: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Further action taken in ongoing EU review of "sartan" products

Interaction between ritonavir products and levothyroxine

Heparin

Leflunomide, prednisone and tacrolimus

Infliximab

Ibuprofen